FMED vs. FSMEX

In the year-to-date period, FMED achieves a 3.87% return, which is significantly higher than FSMEX's 1.90% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

FMED has a 0.50% expense ratio, which is lower than FSMEX's 0.68% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and Fidelity Select Medical Technology and Devices Portfolio (FSMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FMED Sharpe Ratio is 0.22, which is higher than the FSMEX Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of FMED and FSMEX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FMED's dividend yield for the trailing twelve months is around 0.45%, while FSMEX has not paid dividends to shareholders.

The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum FSMEX drawdown of -43.45%. Use the drawdown chart below to compare losses from any high point for FMED and FSMEX. For additional features, visit the drawdowns tool.

The current volatility for Fidelity Disruptive Medicine ETF (FMED) is 4.86%, while Fidelity Select Medical Technology and Devices Portfolio (FSMEX) has a volatility of 8.52%. This indicates that FMED experiences smaller price fluctuations and is considered to be less risky than FSMEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.